Canada authorizes Mo-99 production at Darlington station

November 12, 2021, 9:30AMNuclear News
Darlington nuclear power plant. (Photo: OPG)

The Canadian Nuclear Safety Commission (CNSC) has amended Ontario Power Generation’s (OPG) operating license for its Darlington nuclear power station near Clarington, Ontario, allowing the company to produce the medical radioisotope molybdenum-99 using Darlington’s Unit 2 CANDU reactor. OPG subsidiary Laurentis Energy Partners, in conjunction with BWXT Medical, is leading the program to produce Mo-99 at Darlington.

To continue reading, log in or create a free account!

Related Articles

BWXT Canada awarded major contracts for 2 OPG plants

Work will support Pickering life extension and Darlington SMRs

January 29, 2025, 9:30AMNuclear News

Ontario Power Generation announced this week new contracts with BWXT Canada worth more than C$1 billion ($695.4 million) for projects at the Pickering and Darlington nuclear power plants....